Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 299, doi. 10.1038/sj.mp.4001434
- By:
- Publication type:
- Article
Works matching IS 13594184 AND DT 2004 AND VI 9 AND IP 3
Results: 16
1
2
A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 287, doi. 10.1038/sj.mp.4001420
- By:
- Publication type:
- Article
3
Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 264, doi. 10.1038/sj.mp.4001409
- By:
- Publication type:
- Article
4
Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D<sub>2</sub> receptor gene.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 293, doi. 10.1038/sj.mp.4001422
- By:
- Publication type:
- Article
5
Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 252, doi. 10.1038/sj.mp.4001396
- By:
- Publication type:
- Article
6
Family factors and sampling approach differentially influence attention deficit/hyperactivity disorder subtypes.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 260, doi. 10.1038/sj.mp.4001406
- By:
- Publication type:
- Article
7
Confirmation and fine mapping of the chromosome 1 alcohol dependence risk locus.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 312, doi. 10.1038/sj.mp.4001429
- By:
- Publication type:
- Article
8
Nature and nurture in novelty seeking.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 308, doi. 10.1038/sj.mp.4001433
- By:
- Publication type:
- Article
9
Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 272, doi. 10.1038/sj.mp.4001411
- By:
- Publication type:
- Article
10
The promoter -194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 320, doi. 10.1038/sj.mp.4001443
- By:
- Publication type:
- Article
11
Will haplotype maps be useful for finding genes?
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 227, doi. 10.1038/sj.mp.4001449
- By:
- Publication type:
- Article
12
Blockade of CRF<sub>1</sub> or V<sub>1b</sub> receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 278, doi. 10.1038/sj.mp.4001464
- By:
- Publication type:
- Article
13
St John's wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 237, doi. 10.1038/sj.mp.4001470
- By:
- Publication type:
- Article
14
22q11 deletion syndrome in childhood onset schizophrenia: an update.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 225, doi. 10.1038/sj.mp.4001477
- By:
- Publication type:
- Article
15
Blockade of CRF1 or V1B receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 224, doi. 10.1038/sj.mp.4001484
- By:
- Publication type:
- Article
16
General Summary.
- Published in:
- Molecular Psychiatry, 2004, v. 9, n. 3, p. 221, doi. 10.1038/sj.mp.4001487
- By:
- Publication type:
- Article